The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity
Open accessAbstract
Applications of adenine base editors (ABEs) have been constrained by the limited compatibility of the deoxyadenosine deaminase component with Cas homologs other than SpCas9. We evolved the deaminase component of ABE7.10 using phage-assisted non-continuous and continuous evolution (PANCE and PACE), which resulted in ABE8e. ABE8e contains eight additional mutations that increase activity (k app) 590-fold compared with that of ABE7.10. ABE8e offers substantially improved editing efficiencies when paired with a variety of Cas9 or Cas12 homologs. ABE8e is more processive than ABE7.10, which could benefit screening, disruption of regulatory regions and multiplex base editing applications. A modest increase in Cas9-dependent and -independent DNA off-target editing, and in transcriptome-wide RNA off-target editing can be ameliorated by the introduction of an additional mutation in the TadA-8e domain. Finally, we show that ABE8e can efficiently install natural mutations that upregulate fetal hemoglobin expression in the BCL11A enhancer or in the the HBG promoter in human cells, targets that were poorly edited with ABE7.10. ABE8e augments the effectiveness and applicability of adenine base editing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“ABE8e has an “editing window,” the nucleotides accessible for deamination, of positions 4–9 in the protospacer (11–16 bases upstream from the PAM).16”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, accumulative studies have proved that sgRNA-independent off-target effects also exist, urging unbiased experimental detection and validation (Richter et al., 2020; O'Geen et al., 2015).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Richter et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The sgRNA-independent DNA editing is likely deposited on loci where DNA unwinds into an R-loop so single-strand genomic DNA is exposed to deaminases”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Richter et al., 2020
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ABE8e, a variant published in 2020, exhibits a 590-fold increase in activity due to numerous mutations in the TadA deaminase domain.16”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [16]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Truncated gRNA: truncated by 2-3bp at 5’ end | Decreased off-target effects”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Extended gRNA: GGX20 | Decreased off-target effects”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationShrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Self-citationClinVar: public archive of relationships among sequence variation and human phenotype
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Efficient generation of mouse models of human diseases via ABE- and BE-mediated base editing
Liu, Z., Lu, Z., Yang, G., Huang, S., Li, G., Feng, S., Liu, Y., Li, J., Yu, W., Zhang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04768-7 · Cited by 2,103
Base editing: precision chemistry on the genome and transcriptome of living cells
Rees, H. A., & Liu, D. R. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0059-1 · Cited by 1,675
Self-citationCRISPResso2 provides accurate and rapid genome editing sequence analysis
Clement, K., Rees, H. A., Canver, M. C., Gehrke, J. M., Farouni, R., Hsu, J. Y., Cole, M. A., Liu, D. R., Joung, J. K., Bauer, D. E., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0032-3 · Cited by 1,656
Self-citation
Cited by
Sorted by citations
Items 201–300 of 1,000
PAM-flexible Engineered FnCas9 variants for robust and ultra-precise genome editing and diagnostics
Acharya, S., Ansari, A. H., Das, P. K., Hirano, S., Aich, M., Rauthan, R., Mahato, S., Maddileti, S., Sarkar, S., Kumar, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49233-w · Cited by 47
Helicase-assisted continuous editing for programmable mutagenesis of endogenous genomes
Chen, X. D., Chen, Z., Wythes, G., Zhang, Y., Orr, B. C., Sun, G., Chao, Y.-K., Torres, A. N., Thao, K., Vallurupalli, M., et al. (2024) · Science · doi:10.1126/science.adn5876 · Cited by 47
Emerging applications of gene editing technologies for the development of climate-resilient crops
Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 55
CRISPR-Cas9 base editing of pathogenic CaMKIIδ improves cardiac function in a humanized mouse model
Lebek, S., Caravia, X. M., Straub, L. G., Alzhanov, D., Tan, W. H., Li, H. Z., McAnally, J., Chen, K., Xu, L., Scherer, P. E., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci175164 · Cited by 46
Efficient and high-fidelity base editor with expanded PAM compatibility for cytidine dinucleotide
Liu, Z., Chen, S., Jia, Y., Shan, H., Chen, M., Song, Y., Lai, L., & Li, Z. (2021) · Science China Life Sciences · doi:10.1007/s11427-020-1775-2 · Cited by 35
Universal toxin-based selection for precise genome engineering in human cells
Li, S., Akrap, N., Cerboni, S., Porritt, M. J., Wimberger, S., Lundin, A., Möller, C., Firth, M. A., Gordon, E., Lazovic, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20810-z · Cited by 46
Systems for in vivo hypermutation: a quest for scale and depth in directed evolution
Rix, G., & Liu, C. C. (2021) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2021.02.008 · Cited by 43
Kulcsár, P. I., Tálas, A., Ligeti, Z., Krausz, S. L., & Welker, E. (2022) · Nature Communications · doi:10.1038/s41467-022-34527-8 · Cited by 46
Gene Therapy and Gene Editing for β-Thalassemia
Christakopoulos, G. E., Telange, R., Yen, J. S., & Weiss, M. J. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.12.012 · Cited by 43
Zhang, C., Zhong, X., Li, S., Yan, L., Li, J., He, Y., Lin, Y., Zhang, Y., & Xia, L. (2023) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13543 · Cited by 42
Xiong, X., Li, Z., Liang, J., Liu, K., Li, C., & Li, J.-F. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac166 · Cited by 41
Thean, D., Chu, H. Y., Fong, J. H. C., Chan, B. K. C., Zhou, P., Kwok, C. C. S., Chan, Y. M., Mak, S. Y. L., Choi, G. C. G., Ho, J. W. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29874-5 · Cited by 44
Sun, N., Zhao, D., Li, S., Zhang, Z., Bi, C., & Zhang, X. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.03.023 · Cited by 40
Li, J., Yu, X., Zhang, C., Li, N., & Zhao, J. (2022) · aBIOTECH · doi:10.1007/s42994-022-00076-3 · Cited by 42
Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F
Peters, C. W., Hanlon, K. S., Ivanchenko, M. V., Zinn, E. M., Linarte, E., Li, Y., Levy, J. M., Liu, D. R., Kleinstiver, B. P., Indzhykulian, A. A., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.06.007 · Cited by 36
Self-citationLebek, S., Caravia, X. M., Chemello, F., Tan, W. H., McAnally, J., Chen, K., Xu, L., Liu, N., Bassel‐Duby, R., & Olson, E. N. (2023) · Circulation · doi:10.1161/circulationaha.123.065117 · Cited by 44
Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos
Xue, N., Hong, D., Zhang, D., Wang, Q., Zhang, S., Yang, L., Chen, X., Li, Y., Han, H., Hu, C., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.07.007 · Cited by 45
Multiplexed assays of variant effect for clinical variant interpretation
McEwen, A. E., Tejura, M., Fayer, S., Starita, L. M., & Fowler, D. M. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00870-x · Cited by 52
Marker-free co-selection for successive rounds of prime editing in human cells
Levesque, S., Mayorga, D., Fiset, J.-P., Goupil, C., Duringer, A., Loiselle, A., Bouchard, E., Agudelo, D., & Doyon, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-33669-z · Cited by 41
A most formidable arsenal: genetic technologies for building a better mousePreprint
Clark, J. F., Dinsmore, C. J., & Soriano, P. M. (2020) · Genes & Development · doi:10.1101/gad.342089.120 · Cited by 40
Improving adenine and dual base editors through introduction of TadA-8e and Rad51DBD
Xue, N., Liu, X., Zhang, D., Wu, Y., Zhong, Y., Wang, J., Fan, W., Jiang, H., Zhu, B., Ge, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36887-1 · Cited by 39
The Design and Application of DNA-Editing Enzymes as Base Editors
Rallapalli, K. L., & Komor, A. C. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052521-013938 · Cited by 44
Base editor screens for in situ mutational scanning at scale
Lue, N. Z., & Liau, B. B. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.06.009 · Cited by 43
Mapping variant effects on anti-tumor hallmarks of primary human T cells with base-editing screens
Walsh, Z. H., Shah, P., Kothapalli, N., Shah, S. B., Nikolényi, G., Brodtman, D. Z., Leuzzi, G., Rogava, M., Mu, M., Ho, P., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02235-x · Cited by 42
Engineered IscB–ωRNA system with expanded target range for base editing
Xiao, Q., Li, G., Han, D., Wang, H., Yao, M., Ma, T., Zhou, J., Zhang, Y., Zhang, X., He, B., et al. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01706-1 · Cited by 41
A Tale of Two Moieties: Rapidly Evolving CRISPR/Cas-Based Genome Editing
Yang, L. C., & Chen, J. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.06.003 · Cited by 38
Human cell based directed evolution of adenine base editors with improved efficiency
Fu, J., Li, Q., Liu, X., Tu, T., Lv, X., Yin, X., Lv, J., Song, Z., Qu, J., Zhang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26211-0 · Cited by 35
mRNA-mediated delivery of gene editing tools to human primary muscle stem cells
Stadelmann, C., Francescantonio, S. D., Marg, A., Müthel, S., Spuler, S., & Escobar, H. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.016 · Cited by 39
A split and inducible adenine base editor for precise in vivo base editing
Zeng, H., Yuan, Q., Peng, F., Ma, D., Lingineni, A., Chee, K., Gilberd, P., Osikpa, E. C., Sun, Z., & Gao, X. (2023) · Nature Communications · doi:10.1038/s41467-023-41331-5 · Cited by 37
Revolutionising healing: Gene Editing's breakthrough against sickle cell disease
Dimitrievska, M., Bansal, D., Vitale, M., Strouboulis, J., Miccio, A., Nicolaides, K. H., Hoss, S. E., Shangaris, P., & Jackow, J. (2024) · Blood Reviews · doi:10.1016/j.blre.2024.101185 · Cited by 41
Docking sites inside Cas9 for adenine base editing diversification and RNA off-target elimination
Li, S., Yuan, B., Cao, J., Chen, J., Chen, J., Qiu, J., Zhao, X., Wang, X., Qiu, Z., & Cheng, T. (2020) · Nature Communications · doi:10.1038/s41467-020-19730-9 · Cited by 35
CRISPR–Cas12a base editors confer efficient multiplexed genome editing in rice
Cheng, Y., Zhang, Y., Li, G., Fang, H., Sretenovic, S., Fan, A., Li, J., Xu, J., Que, Q., & Qi, Y. (2023) · Plant Communications · doi:10.1016/j.xplc.2023.100601 · Cited by 36
Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors
Chen, F., Lian, M., Ma, B., Gou, S., Luo, X., Yang, K., Shi, H., Xie, J., Ge, W., Ouyang, Z., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04152-8 · Cited by 36
Engel, N. W., Steinfeld, I., Ryan, D., Anupindi, K., Kim, S., Wellhausen, N., Chen, L., Wilkins, K., Baker, D. J., Rommel, P. C., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2427216122 · Cited by 39
Cornean, A., Gierten, J., Welz, B., Mateo, J. L., Thumberger, T., & Wittbrodt, J. (2022) · eLife · doi:10.7554/elife.72124 · Cited by 35
Li, S., Liu, L., Sun, W., Zhou, X., & Zhou, H. (2022) · Genome biology · doi:10.1186/s13059-022-02618-w · Cited by 35
Current advances of CRISPR-Cas technology in cell therapy
Qiu, H.-Y., Ji, R.-J., & Zhang, Y. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100067 · Cited by 38
TadA reprogramming to generate potent miniature base editors with high precision
Zhang, S., Song, L., Yuan, B., Zhang, C., Cao, J., Chen, J., Qiu, J., Tai, Y., Chen, J., Qiu, Z., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36004-2 · Cited by 40
Cytosine base editors induce off-target mutations and adverse phenotypic effects in transgenic mice
Yan, N., Feng, H., Sun, Y., Xin, Y., Zhang, H., Lu, H., He, C., He, C., Zuo, Z., Yuan, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37508-7 · Cited by 37
Assessing and engineering the IscB–ωRNA system for programmed genome editing
Yan, H., Tan, X., Zou, S., Sun, Y., Ke, A., & Tang, W. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01669-3 · Cited by 36
Effective genome editing with an enhanced ISDra2 TnpB system and deep learning-predicted ωRNAs
Marquart, K. F., Mathis, N., Mollaysa, A., Müller, S., Kissling, L., Rothgangl, T., Schmidheini, L., Kulcsár, P. I., Allam, A., Kaufmann, M. M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02418-z · Cited by 41
The road toward AAV-mediated gene therapy of Duchenne muscular dystrophy
Bengtsson, N. E., Tasfaout, H., & Chamberlain, J. S. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.065 · Cited by 36
CRISPR/Cas Technologies and Their Applications in Escherichia coli
Dong, H., Cui, Y., & Zhang, D. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.762676 · Cited by 35
Strategies for High-Efficiency Mutation Using the CRISPR/Cas System
Feng, S., Wang, Z., Li, A., Xie, X., Liu, J., Li, S., Li, Y., Wang, B., Hu, L., Yang, L., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.803252 · Cited by 40
Selective Xi reactivation and alternative methods to restore MECP2 function in Rett syndrome
Grimm, N.-B., & Lee, J. T. (2022) · Trends in Genetics · doi:10.1016/j.tig.2022.01.007 · Cited by 34
Shi, Y.-J., Duan, M., Ding, J., Wang, F.-Q., Bi, L.-L., Zhang, C.-X., Zhang, Y., Duan, J.-Y., Huang, A.-H., Lei, X., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.09.032 · Cited by 35
An engineered xCas12i with high activity, high specificity and broad PAM range
Zhang, H., Kong, X., Xue, M., Hu, J., Wang, Z., Wei, Y., Wang, H., Zhou, J., Zhang, W., Xu, M., et al. (2022) · Protein & Cell · doi:10.1093/procel/pwac052 · Cited by 35
Amistadi, S., Maule, G., Ciciani, M., Ensinck, M. M., Keersmaecker, L. D., Ramalho, A. S., Guidone, D., Buccirossi, M., Galietta, L. J. V., Carlon, M. S., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.03.004 · Cited by 35
Enhancing prime editor activity by directed protein evolution in yeast
Weber, Y., Böck, D., Ivascu, A., Mathis, N., Rothgangl, T., Ioannidi, E. I., Blaudt, A. C., Tidecks, L., Vadovics, M., Muramatsu, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46107-z · Cited by 37
Merlin, J. P. J., & Abrahamse, H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117516 · Cited by 35
Evolution-guided protein design of IscB for persistent epigenome editing in vivo
Kannan, S., Altae-Tran, H., Zhu, S., Xu, P., Strebinger, D., Oshiro, R., Faure, G., Moeller, L., Pham, J., Mears, K. S., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02655-3 · Cited by 40
Synthetic evolution of herbicide resistance using a T7 RNAP–based random DNA base editor
Butt, H., Moreno, J. L., & Mahfouz, M. M. (2022) · Life Science Alliance · doi:10.26508/lsa.202201538 · Cited by 34
Kabra, M., Shahi, P. K., Wang, Y., Sinha, D., Spillane, A., Newby, G. A., Saxena, S., Tong, Y., Chang, Y., Abdeen, A. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171356 · Cited by 36
Self-citationCui, C., Wang, S., Wang, D., Zhao, J., Huang, B., Zhu, B., Chen, Y., Tang, H., Han, Y., Cheng, Y., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01235-1 · Cited by 35
Engineering Cas9 for human genome editing
Slaymaker, I. M., & Gaudelli, N. M. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.03.004 · Cited by 34
Diverse Approaches to Gene Therapy of Sickle Cell Disease
White, S. L., Hart, K. L., & Kohn, D. B. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-021707 · Cited by 33
Shelake, R. M., Pramanik, D., & Kim, J. (2023) · mBio · doi:10.1128/mbio.02296-22 · Cited by 34
Reversing the Central Dogma: RNA-guided control of DNA in epigenetics and genome editing
Chang, H. Y., & Qi, L. S. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.01.010 · Cited by 33
Base editors: development and applications in biomedicine
Liang, Y., Chen, F., Wang, K., & Lai, L. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1013-y · Cited by 33
Joint genotypic and phenotypic outcome modeling improves base editing variant effect quantification
Ryu, J., Barkal, S., Yu, T., Jankowiak, M., Zhou, Y., Francoeur, M., Phan, Q. V., Li, Z., Tognon, M., Brown, L., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01726-6 · Cited by 33
Xu, K., Feng, H., Zhang, H., He, C., Kang, H., Yuan, T., Shi, L., Zhou, C., Hua, G., Cao, Y., et al. (2024) · Nature Biomedical Engineering · doi:10.1038/s41551-024-01220-8 · Cited by 36
Huang, X., Xiao, N., Xie, Y., & Cao, X. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.03.007 · Cited by 32
PPP2R1A mutations portend improved survival after cancer immunotherapy
Dai, Y., Knisely, A. T., Yano, M., Dang, M., Hinchcliff, E., Lee, S., Welp, A. M., Chelvanambi, M., Lastrapes, M. J., Liu, H., et al. (2025) · Nature · doi:10.1038/s41586-025-09203-8 · Cited by 32
Elsharkasy, O. M., Hegeman, C. V., Driedonks, T. A. P., Liang, X., Lansweers, I., Cotugno, O. L., de Groot, I. Y., de Wit, Z. E. M. N. J., Garcia-Guerra, A., Moorman, N. J. A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65995-3 · Cited by 37
Applications and Major Achievements of Genome Editing in Vegetable Crops: A Review
Kim, Y., Kang, Y., Yang, E.-Y., Cho, M.-C., Schafleitner, R., Lee, J. H., & Jang, S. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.688980 · Cited by 33
A dual gene-specific mutator system installs all transition mutations at similar frequencies in vivo
Seo, D., Koh, B., Eom, G.-E., Kim, H. W., & Kim, S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad266 · Cited by 32
Directed evolution rice genes with randomly multiplexed sgRNAs assembly of base editors
Zhang, A., Shan, T., Sun, Y., Chen, Z., Hu, J., Hu, Z., Ming, Z., Zhu, Z., Li, X., He, J., et al. (2023) · Plant Biotechnology Journal · doi:10.1111/pbi.14156 · Cited by 34
Split complementation of base editors to minimize off-target edits
Xiong, X., Liu, K., Li, Z., Xia, F., Ruan, X.-M., He, X., & Li, J. (2023) · Nature Plants · doi:10.1038/s41477-023-01540-8 · Cited by 32
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
Chai, A. C., Chemello, F., Li, H. Z., Nishiyama, T., Chen, K., Zhang, Y., Sanchez‐Ortiz, E., Alomar, A., Xu, L., Liu, N., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.009 · Cited by 32
Multimodal scanning of genetic variants with base and prime editing
Belli, O., Karava, K., Farouni, R., & Platt, R. J. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02439-1 · Cited by 34
Genome Editing for β-Hemoglobinopathies: Advances and Challenges
Frati, G., & Miccio, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030482 · Cited by 31
High-throughput methods for genome editing: the more the better
Huang, Y., Shang, M., Liu, T., & Wang, K. (2022) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiac017 · Cited by 32
Direct correction of haemoglobin E β-thalassaemia using base editors
Badat, M., Ejaz, A., Peng, H., Rice, S., Zhang, W., Hentges, L. D., Fisher, C. A., Denny, N., Schweßinger, R., Yasara, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37604-8 · Cited by 30
Advances in ultrahigh-throughput screening technologies for protein evolution
Liu, Z., Chen, S., & Wu, J. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.03.010 · Cited by 30
Breaking genetic shackles: The advance of base editing in genetic disorder treatment
Xu, F., Zheng, C., Xu, W., Zhang, S., Liu, S., Chen, X., & Yao, K. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1364135 · Cited by 32
Han, H., Wu, Z., Zheng, L., Han, J., Zhang, Y., Li, J., Zhang, S., Li, G., Ma, C., & Wang, P. (2021) · The Crop Journal · doi:10.1016/j.cj.2021.08.006 · Cited by 30
Hao, W., Cui, W., Suo, F., Han, L., Cheng, Z., & Zhou, Z. (2022) · Chemical Science · doi:10.1039/d2sc05824c · Cited by 30
Kim, H. S., Grimes, S. M., Chen, T., Sathe, A., Lau, B. T., Hwang, G., Bae, S., & Ji, H. P. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01949-8 · Cited by 31
ABE-ultramax for high-efficiency biallelic adenine base editing in zebrafish
Qin, W., Liang, F., Lin, S., Petree, C., Huang, K., Zhang, Y., Li, L., Varshney, P., Mourrain, P., Liu, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49943-1 · Cited by 30
Harnessing the evolving CRISPR/Cas9 for precision oncology
Li, T., Li, S., Kang, Y., Zhou, J., & Yi, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05570-4 · Cited by 35
Base editing repairs an SGCA mutation in human primary muscle stem cells
Escobar, H., Krause, A., Keiper, S., Kieshauer, J., Müthel, S., de Paredes, M. G., Metzler, E., Kühn, R., Heyd, F., & Spuler, S. (2021) · JCI Insight · doi:10.1172/jci.insight.145994 · Cited by 29
Phage-Assisted Continuous Evolution and Selection of Enzymes for Chemical Synthesis
Jones, K. A., Snodgrass, H. M., Belsare, K. D., Dickinson, B. C., & Lewis, J. C. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00811 · Cited by 29
Ryan, D. E., Diamant-Levi, T., Steinfeld, I., Taussig, D., Visal-Shah, S., Thakker, S., Lunstad, B. D., Kaiser, R. J., McCaffrey, R. M., Ortiz, M., et al. (2022) · Biochemistry · doi:10.1021/acs.biochem.1c00768 · Cited by 30
Scalable biological signal recording in mammalian cells using Cas12a base editors
Kempton, H. R., Love, K. S., Guo, L. Y., & Qi, L. S. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01034-2 · Cited by 30
Bisen, M., Kharga, K., Mehta, S., Jabi, N., & Kumar, L. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-32535-3 · Cited by 31
He, Y., Han, Y., Ma, Y., Liu, S., Fan, T., Liang, Y., Tang, X., Zheng, X., Wu, Y., Zhang, T., et al. (2024) · Plant Biotechnology Journal · doi:10.1111/pbi.14363 · Cited by 29
Multiplex CRISPR-Cas Genome Editing: Next-Generation Microbial Strain Engineering
Lim, S. R., & Lee, S. J. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01650 · Cited by 28
Bzhilyanskaya, V., Ma, L., Liu, S., Fox, L. R., Whittaker, M. N., Meis, R. J., Choi, U., Lawson, A., Ma, M., Theobald, N., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj6779 · Cited by 27
Repairing a deleterious domestication variant in a floral regulator gene of tomato by base editing
Glaus, A. N., Brechet, M., Swinnen, G., Lebeigle, L., Iwaszkiewicz, J., Ambrosini, G., Julca, I., Zhang, J., Roberts, R., Iseli, C., et al. (2025) · Nature Genetics · doi:10.1038/s41588-024-02026-9 · Cited by 28
Dual SORT LNPs for multi-organ base editing
Kim, M., Song, E. S., Chen, J. C., Chatterjee, S., Sun, Y., Lee, S. M., Wu, S., Patel, P., Tian, Z., Kantor, A., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02675-z · Cited by 39
Efficient mitochondrial A-to-G base editors for the generation of mitochondrial disease models
Chen, L., Hong, M., Luan, C., Yuan, M., Wang, Y., Guo, X., Fang, Y., Huang, H., Dong, X., Gao, H., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02685-x · Cited by 28
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial
Wan, P., Tang, S., Yang, T., Lu, Y., Long, M., Xiao, L., Jiang, Y., Liao, J., Ma, X., Liu, Y., et al. (2025) · Nature Medicine · doi:10.1016/j.atherosclerosis.2025.119507 · Cited by 41
Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9
Liu, Z., Chen, S., Xie, W., Song, Y., Li, J., Lai, L., & Li, Z. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.013 · Cited by 29
Genome editing with type II‐C CRISPR‐Cas9 systems from Neisseria meningitidis in rice
Xu, R., Qin, R., Xie, H., Li, J., Liu, X., Zhu, M., Sun, Y., Yu, Y., Lu, P., & Wei, P. (2021) · Plant Biotechnology Journal · doi:10.1111/pbi.13716 · Cited by 29
Ji, R.-J., Cao, G.-H., Zhao, W., Wang, M.-Y., Gao, P., Zhang, Y.-Z., Wang, X.-B., Qiu, H.-Y., Chen, D.-D., Tong, X.-H., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.003 · Cited by 30
Arantes, P. R., Chen, X., Sinha, S., Saha, A., Patel, A. C., Sample, M., Nierzwicki, Ł., Lapinaitė, A., & Palermo, G. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1066 · Cited by 27
CRISPR-based therapeutic genome editing for inherited blood disorders
Levesque, S., & Bauer, D. E. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01236-y · Cited by 31
Self-citationGenome editing approaches to β-hemoglobinopathies
Brusson, M., & Miccio, A. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.025 · Cited by 29
Brooks, D. L., Whittaker, M. N., Said, H., Dwivedi, G., Qü, P., Musunuru, K., Ahrens‐Nicklas, R. C., Alameh, M., & Wang, X. (2023) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2023.100253 · Cited by 33
Expanded palette of RNA base editors for comprehensive RBP-RNA interactome studies
Medina-Muñoz, H. C., Kofman, E. R., Jagannatha, P., Boyle, E. A., Yu, T., Jones, K. L., Mueller, J. R., Lykins, G. D., Doudna, A. T., Park, S. S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45009-4 · Cited by 27
Metadata
- Authors
- Richter, M. F., Zhao, K. T., Eton, E., Lapinaite, A., Newby, G. A., Thuronyi, B. W., Wilson, C., Koblan, L. W., Zeng, J., Bauer, D. E., Doudna, J. A., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2020-03-16
- Volume
- 38
- Issue
- 7
- Pages
- 883-891
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC7357821
- OpenAlex
- W3012327875
- Cited by
- 1,020
- References
- 60
- Citations by year
- 2026: 158 · 2025: 196 · 2024: 192 · 2023: 192 · 2022: 148 · 2021: 103 · 2020: 29
- FWCI
- 38.37
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-05-20)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01HL053749)
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01 AI142756)
- U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
- U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB022376)
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- adenine base editing, ABE8e, phage-assisted continuous evolution, Cas12, processivity, off-target editing, fetal hemoglobin, PAM site
- MeSH terms
- Gene Editing, Adenine, Adenosine Deaminase, Bacteriophages, DNA, Humans, Mutation, RNA, Mutagenesis, HEK293 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review